BRAF and colonic neoplasm: This case series included nine patients (4 had primary tumors on the right side: 2 in ascending colon and 2 in transverse colon; and 5 on the left side: 3 in descending colon cancer and 2 in sigmoid colon) with BRAF V600E-mutated mCRC who underwent triplet therapy.